Reference
Farschtschi S, et al. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2. Acta Neurologica Scandinavica 133: 475-480, No. 6, Jun 2016. Available from: URL: http://doi.org/10.1111/ane.12490 - Germany
Rights and permissions
About this article
Cite this article
Bevacizumab. Reactions Weekly 1604, 35 (2016). https://doi.org/10.1007/s40278-016-18091-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-18091-5